Pear Therapeutics (PEAR) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free PEAR Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVirtual Clinic Pelago Is Reimagining Rehab With $58 Million In New Fundingforbes.com - March 28 at 10:33 AMGirl's rare disease inspired new drug model. Now the drug trial has hit a pivotal pointbizjournals.com - March 19 at 2:40 AMBetter Therapeutics lays off staff, considers winding down businessfinance.yahoo.com - March 15 at 3:56 PMBratu named marketing and development director for State Gamesfinance.yahoo.com - March 14 at 2:31 AMBetter Therapeutics wins breakthrough status for health app to treat liver diseasefinance.yahoo.com - February 21 at 5:00 PMGlobal Internet Addiction Disorder Market Size Is Expected To Hold a Significant Share By 2033 | CAGR of 11.45%finance.yahoo.com - January 31 at 10:29 PMSmart Pills Market Set to Soar Past USD 12.39 billion by 2030finance.yahoo.com - January 31 at 10:29 PMHow Pharma Can Borrow A Page From Digital Health Investors’ Playbookforbes.com - January 31 at 10:29 PMCognito Therapeutics raises $35M for neuro deviceaxios.com - January 31 at 10:29 PMHealthcare bankruptcies reached five-year peak in 2023, report findsfinance.yahoo.com - January 26 at 9:31 PMAcorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025finance.yahoo.com - January 11 at 9:42 AMDigital Therapeutics Global Market to Observe Stunning Growth at a CAGR of ~28% by 2028 | DelveInsightfinance.yahoo.com - December 20 at 3:08 PMPear Therapeutics Inc Class A PEARQmorningstar.com - November 11 at 8:14 PMNox Health Appoints Frances Thorndike, Ph.D. to lead Medical & Scientific Affairsfinance.yahoo.com - November 9 at 8:15 PMPEARQ Pear Therapeutics, Inc.seekingalpha.com - October 27 at 2:33 PMDigital Therapeutics Market Is Projected to Gain $22.60 Billion By 2031, Growing at a 19.4% CAGR: Allied Market Researchbenzinga.com - October 24 at 1:50 AMDeals of the Year: Somryst 'literally completes our portfolio,' Nox Health CEO saysbizjournals.com - October 18 at 1:09 PMBiotech's 2023 ghosts haunt efforts to exorcise downturnbizjournals.com - October 10 at 10:21 AMMigraine Pipeline, Clinical Trials, Emerging Therapies and FDA Approvals 2023 (Updated)benzinga.com - September 28 at 8:33 PMPear Therapeutics, Inc. (PEARQ)finance.yahoo.com - September 25 at 12:42 AMADHD video game maker Akili shifts focus from prescription to OTC, lays off 40%axios.com - September 14 at 5:33 PMDigital health startup Akili cuts staff by 40%, abandons prescription modelbizjournals.com - September 13 at 4:30 PMShaping the Future of Medicine: Anticipated $17.7 Billion Digital Therapeutics Market by 2027benzinga.com - August 28 at 8:42 PMFormer execs from defunct Pear Therapeutics start VC firmmsn.com - August 23 at 4:24 PMStartups Struggle With Insurers Over Digital Treatmentsmsn.com - July 27 at 10:15 AMBiotech layoffs 2023: In Q2, more than 700 Boston-area life science jobs were cutbizjournals.com - July 3 at 8:28 AMPrescription Digital Therapeutics For Mental Health: What It Means For Doctors And Their Patientsforbes.com - June 26 at 3:37 PMDigital Therapeutics (DTx) Market Research Report 2023 Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030marketwatch.com - June 22 at 2:35 PMNox Health Closes Acquisition of Somryst, the Only FDA-Cleared Digital Insomnia Treatment, From Pear Therapeuticsfinance.yahoo.com - June 20 at 4:30 PMBehaVR adds 3 executives to senior leadership teambizjournals.com - June 12 at 6:25 PMGlobal Digital Therapeutics [DTx] for Mental Health Market Sizefinance.yahoo.com - June 8 at 11:04 AMBehaVR Appoints Former Pear Therapeutics, TytoCare and AVIA Executives to Senior Leadership Teamfinance.yahoo.com - June 8 at 11:04 AMPear Therapeutics sold for partsaxios.com - May 22 at 2:31 PMDigital Therapeutics Market 2023 Industry Trends, Growth, Size, Segmentation, Opportunities and Revenue by Forecast to 2031marketwatch.com - May 16 at 3:25 PMChardan Capital Reaffirms Their Buy Rating on Orchestra BioMed Holdings (OBIO)markets.businessinsider.com - May 14 at 10:59 PMSeres Therapeutics (MCRB) Gets a Buy from Chardan Capitalmarkets.businessinsider.com - May 9 at 11:26 PMPear Therapeutics Inc (PEARQ)investing.com - May 9 at 8:23 AMChardan Capital Remains a Buy on Omega Therapeutics (OMGA)markets.businessinsider.com - May 5 at 6:25 PMChardan Capital Sticks to Its Buy Rating for Alnylam Pharma (ALNY)markets.businessinsider.com - May 4 at 10:24 PMFirm Retention Summary: Pear Therapeuticswsj.com - May 3 at 6:50 PMDigital Therapeutics (DTx) Market Growth Strategies, Size, Geography Trends and Competitive Analysis to 2030marketwatch.com - April 29 at 12:26 AMIt's Down 82% But Pear Therapeutics, Inc. (NASDAQ:PEAR) Could Be Riskier Than It Looksfinance.yahoo.com - April 17 at 8:51 AMWhy Navidea Biopharmaceuticals Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarketmsn.com - April 14 at 9:50 AMWhy Is Pear Therapeutics (PEAR) Stock Down 26% Today?msn.com - April 14 at 9:50 AMPear Therapeutics Shares Touch All-Time Low After Chapter 11 Filingmarketwatch.com - April 11 at 3:30 PMPear Therapeutics shares are trading lower after the company filed for Chapter 11 and said it will seek to sell its assets through a sales process.benzinga.com - April 10 at 6:44 PMAfter blazing a trail in digital therapeutics, Pear goes bankruptaxios.com - April 10 at 1:43 PMCEO announces layoffs - 'Most difficult decision we've had to make since starting of company'msn.com - April 10 at 8:43 AMPear Therapeutics Files For Bankruptcy As CEO Blames Shortfalls On Insurersforbes.com - April 8 at 12:48 AMMaker of first FDA-approved prescription software files for bankruptcy, ousts CEObizjournals.com - April 7 at 7:48 PM Get Pear Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PEAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… PEAR Media Mentions By Week PEAR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PEAR News Sentiment▼0.000.61▲Average Medical News Sentiment PEAR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PEAR Articles This Week▼11▲PEAR Articles Average Week Get Pear Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PEAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GOVX News BSGM News SRNE News PXMD News ARTL News NAVB News HSDT News FNCH News VERO News KZIA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PEAR) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pear Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.